EARNEST Partners’s Abiomed Inc ABMD Stock Holding History

EARNEST Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23	Closed	-$6K	–	1183
2022 Q3	$6K	Hold	23	–	–	﹤0.01%	741
2022 Q2	$6K	Hold	23	–	–	﹤0.01%	766
2022 Q1	$8K	Hold	23	–	–	﹤0.01%	722
2021 Q4	$8K	Hold	23	–	–	﹤0.01%	748
2021 Q3	$7K	Hold	23	–	–	﹤0.01%	775
2021 Q2	$7K	Hold	23	–	–	﹤0.01%	778
2021 Q1	$7K	Hold	23	–	–	﹤0.01%	754
2020 Q4	$7K	Hold	23	–	–	﹤0.01%	735
2020 Q3	$6K	Hold	23	–	–	﹤0.01%	728
2020 Q2	$6K	Hold	23	–	–	﹤0.01%	708
2020 Q1	$3K	Hold	23	–	–	﹤0.01%	855
2019 Q4	$4K	Hold	23	–	–	﹤0.01%	879
2019 Q3	$4K	Hold	23	–	–	﹤0.01%	852
2019 Q2	$6K	Hold	23	–	–	﹤0.01%	734
2019 Q1	$7K	Hold	23	–	–	﹤0.01%	665
2018 Q4	$7K	Hold	23	–	–	﹤0.01%	639
2018 Q3	$10K	Hold	23	–	–	﹤0.01%	590
2018 Q2	$9K	Buy	23 +11	+92%	+$3.98K	﹤0.01%	617
2018 Q1	$3K	Hold	12	–	–	﹤0.01%	952
2017 Q4	$2K	Buy	+12	New	+$2.24K	﹤0.01%	1044
2017 Q1	–	Sell	-12	Closed	-$1K	–	984
2016 Q4	$1K	Buy	+12	New	+$1.39K	﹤0.01%	1095

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

EARNEST Partners's ABMD Position: Q4 2022 in Review

EARNEST Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 23 shares — an estimated $6K sold.

EARNEST Partners first reported a position in ABMD in Q4 2016 and held it in 21 quarters. The position peaked at $10K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

EARNEST Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
EARNEST Partners sold 23 Abiomed Inc shares in Q4 2022, an estimated $6K.
EARNEST Partners first reported a position in Abiomed Inc in Q4 2016 and held it in 21 quarters.
EARNEST Partners's Abiomed Inc position peaked at $10K in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on EARNEST Partners's 13F filing for Q4 2022, filed 14 Feb 2023.